UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000008913
Receipt number R000010454
Scientific Title Comparison of the effects of celiprolol and bisoprolol on central BP and measures of atherosclerosis in hypertensive patients.
Date of disclosure of the study information 2012/09/13
Last modified on 2013/09/14 08:51:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Comparison of the effects of celiprolol and bisoprolol on central BP and measures of atherosclerosis in hypertensive patients.

Acronym

Comparative study between celiprolol and bisoprolol (CB trial)

Scientific Title

Comparison of the effects of celiprolol and bisoprolol on central BP and measures of atherosclerosis in hypertensive patients.

Scientific Title:Acronym

Comparative study between celiprolol and bisoprolol (CB trial)

Region

Japan


Condition

Condition

Hypertensive patients.

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To compare the effects of two different types of beta blockers, celiprolol and bisoprolol, on central BP, endotherial function, autonomic nerve functions, and glucose and lipid metabolism in hypertensive patients.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

1.Effects on casual blood pressure
Extent of BP reduction (SBP, DBP, and mean BP)
2.Ambulatory BP
Extent of BP reduction (SBP, DBP, and mean BP)
3.Pulse wave velocity (PWV), pulse wave analysis (PWA), augmentation index (AI) , central BP
4.The effects on the measures of cardiac and renal target organ damage (urinary microalbumin, hsCRP, hsTroponin T, BNP, NT-proBNP)
5.Effects on glucose and lipid
6.Effects on the measures of insulin resistance (HOMA-R)
7.Effects on autonomic nervous functions (CVRR, BRS etc)

Key secondary outcomes

Adverse effects, and safety measures.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Administer celiprolol 100mg from the beginning and titrated up to 200mg for a total of 12 weeks. If the clinic BP is 140/90mmHg or more at the time of 4th week, the dose will be increased from 100 to 200mg.

Interventions/Control_2

Administer bisoprolol 2.5mg from the beginning and titrated up to 5mg for a total of 12 weeks. If the clinic BP is 140/90mmHg or more at the time of 4th week, the dose will be increased from 2.5 to 5mg.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

25 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1.The Age>=25 years
2.Hypertensive patients
3.Patients who are not taking beta blockers
4. Secondary hypertension will be included

Key exclusion criteria

1.Patients with malignant hypertension
2.Decompensated heart failure (NYHA III or IV)
3. Malignancy needing treatment
4.Hepatic or renal disease (serum creatinine >3.0mg/dl or under hemodialysis)
5.Those who had had severe side effects with beta blockers
6.Those with contraindication for beta blockers (bronchial asthma, bradycardia, vasospastic angina, pregnant women etc.)
7.Those with hyper- or hypoglycemic attack
8. Those with dementia from whom we cannot obtain informed consent.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kazuo Eguchi

Organization

Jichi Medical University School of Medicine

Division name

Division of Cardiovascular Medicine,Department of Medicine

Zip code


Address

3311-1 Yakushiji, Shimotsuke, Tochigi 329-0498, Japan

TEL

0285-58-7344

Email



Public contact

Name of contact person

1st name
Middle name
Last name Kazuo Eguchi

Organization

Jichi Medical University School of Medicine

Division name

Division of Cardiovascular Medicine,Department of Medicine

Zip code


Address

3311-1 Yakushiji, Shimotsuke, Tochigi 329-0498, Japan

TEL

0285-58-7344

Homepage URL


Email

ke112@jichi.ac.jp


Sponsor or person

Institute

Jichi Medical University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Jichi Medical University School of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

International University of Health and Welfare Hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2012 Year 09 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2011 Year 02 Month 03 Day

Date of IRB


Anticipated trial start date

2011 Year 02 Month 04 Day

Last follow-up date

2013 Year 07 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2012 Year 09 Month 13 Day

Last modified on

2013 Year 09 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010454


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name